AEG vs LYV: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of October 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: AEG is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. AEG and LYV share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined AEG and LYV exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Aegon Ltd is a life insurance and retirement group whose center of gravity has shifted almost entirely to the United States. The dominant business is Transamerica, which sells individual life insurance, annuities, workplace retirement plans and mutual funds, and distributes much of that through World Financial Group, an agent network that passed 100,000 licensed agents in the first half of 2026. Outside the US, the group runs a UK workplace pensions and adviser platform, a joint venture with Santander across Spain and Portugal, an interest in Mongeral Aegon in Brazil, and an asset management arm. The company sold its Dutch insurance operations to a.s.r. in 2023 and has been steadily simplifying what remains. Roughly 12,100 people work there, and the reporting currency is still the euro even though the earnings are overwhelmingly dollar-denominated.

Full AEG guide

Live Nation Entertainment runs three linked businesses. Concerts promotes tours, festivals and shows and operates a large global venue network, from clubs and theaters to amphitheaters and arenas. Ticketing is Ticketmaster, which sells primary and resale tickets for venues, sports teams and promoters and earns service fees on each ticket. Sponsorship and Advertising sells brand partnerships, naming rights and on-site and online advertising around its events and platforms. Concerts produce most of the revenue at low single digit margins, while Ticketmaster and sponsorship produce most of the profit. In 2025 the company drew ~159M fans and reported record revenue of ~$25.2B and adjusted operating income (AOI) of ~$2.4B.

Full LYV guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• AEG drivers: Becoming an American company on paper, not just in practice; Capital generation drives a mechanical return of cash.
• LYV drivers: Global concert demand and Venue Nation; Ticketmaster economics.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The legacy American book is the reason the multiple is low: Transamerica carries long-term care and older universal life liabilities whose reserve adequacy depends on morbidity, mortality, lapse and claim-cost assumptions that get revisited annually, and an adverse review can wipe out a year of earnings growth in one press release. For LYV, the largest risk is legal and structural.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick AEG if you believe its drivers more; LYV if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the AEG and LYV guides.

AEG. Aegon reports in euros on a half-yearly calendar, so the trailing US-dollar figures above come from Yahoo Finance conversions and will not line up exactly with the company's own releases. The latest print was the first-half 2026 report on August 20, 2026, in which management said Transamerica's operating result rose about 10 percent and its operating capital generation about 35 percent; the next substantive results are the full-year 2026 figures, expected early in 2027. At roughly 9 times forward earnings and a yield near 6%, the shares still price in a discount that the October 2026 redomiciliation approval has not yet closed.

LYV. Because the ~$450M litigation accrual cut first half 2026 reported operating income by ~75% while AOI rose ~4%, investors typically value LYV on AOI or free cash flow rather than GAAP earnings. Adjusted free cash flow was ~$691M for the first half, and management expects AOI-to-free-cash-flow conversion at or above 2025 levels. Shares closed near $171 on October 16, 2026, against a 52-week range of ~$125 to $189, and the average analyst target is ~$202. The market value moves sharply on legal news, so the valuation partly prices the odds of a breakup.

Headline figures (approximate, October 2026): AEG shows share price / market cap ~$8.37 (Oct 16, 2026), ~$12.4 billion, share price change ~+8% YTD, ~+11% over 1 year, ~-8% over 3 months, revenue (ttm) ~$11.7 billion, latest reported period down ~8% year over year, net income (ttm) ~$970 million, EPS ~$0.69; profit margin ~8.6%; LYV shows revenue (ttm to q2 2026) ~$26.3B (Q2 2026 up ~9% year over year), adjusted operating income (fy2025) ~$2.4B, a record, q2 2026 revenue / aoi ~$7.7B / ~$817M (AOI up ~2%), market cap ~$40B (shares ~$171, mid October 2026).

AEG and LYV are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined AEG and LYV exposure against your real portfolio. It is not an investment adviser.